Skip to content

Effect of Virtual Reality on Perceived Stress in Neonatal Intensive Care Staff

Effect of using Virtual Reality on Perceived Stress in Neonatal Intensive Care Staff: A Randomized Controlled trial (Virtual Reality fOr Our Minds (VrROOM) Study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622001012763
Acronym
VrROOM
Enrollment
33
Registered
2022-07-19
Start date
2024-09-12
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Health care professionals (HCP) working in neonatal intensive care units (NICUs) experience high levels of physical and psychological stress. Nijland and colleagues investigated the ease of use and immediate effect of virtual reality relaxation/ VRRelax (360º immersive environments) to reduce perceived stress in intensive care nurses. After using VRelax, stress levels decreased by 40% and 62% of the ICU nurses thought VRelax was helpful in reducing stress. This study concluded that VR is easy to use and is an effective intervention to reduce immediate stress in ICU nurses. Given these potential benefits, we aim to conduct a pilot study to examine the use of VR to reduce perceived stress in our neonatal intensive care staff during their work shifts.

Interventions

Participants will be exposed to either virtual relaxation (VR) in the first period, followed by no VR in the second treatment period, or no VR in the first period, followed by VR in the second period. The participant shall be directed to the respective rooms labelled as intervention or control by a facilitator depending on the allocation. Participants in the VR immersion (intervention group) will wear the VR headset (Meta Quest 2) and choose one of the following apps: scenic walk, meditation

Participants will be exposed to either virtual relaxation (VR) in the first period, followed by no VR in the second treatment period, or no VR in the first period, followed by VR in the second period. The participant shall be directed to the respective rooms labelled as intervention or control by a facilitator depending on the allocation. Participants in the VR immersion (intervention group) will wear the VR headset (Meta Quest 2) and choose one of the following apps: scenic walk, meditation with relaxing music or physical activity (eg: virtual tennis) based on their preferences in a specific room allocated for the study. Considering the short break times during high acuity workload, the participants will experience VR relaxation for 10 minutes per session; and only one session for the duration of their shift. They will be eligible to receive a maximum of 3 sessions per week over the intervention period of 2 weeks. Participants in the control group will have routine breaks without the VR experience. The enrolled participants will undergo a washout period of two weeks during which they will not be assessed for their stress levels. As part of the crossover design, the participants in the intervention arm shall then be switched over to the control arm and those in the control arm shall then switch over to the intervention arm. They will then be assessed for stress using the same scales and time points as specified for the same shift pattern as in the previous arm.

Sponsors

King Edward Memorial Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

All healthcare providers (HCPs) in the tertiary NICU irrespective of their duration of employment or shift type (day/ night) or shift duration.

Exclusion criteria

HCPs with photosensitive epilepsy or significant cardiopulmonary disease will be excluded from the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026